Link to this page
Medical Subject Headings
Last uploaded:
August 28, 2024
Jump to:
| Preferred Name | pegfilgrastim | |
| Synonyms |
PEG SD-01 lipegfilgrastim SD-01-filgrastim XM22 N-(3-hydroxypropyl)methionylcolony-stimulating factor (human), 1-ether with alpha-methyl-omega-hydroxypoly(oxyethylene) PEG-rmetHuG-CSF XM-22 Neulasta SD-01, polyethylene glycol-conjugated filgrastim LA-EP2006 |
|
| ID |
http://purl.bioontology.org/ontology/MESH/C455861 |
|
| altLabel |
PEG SD-01 lipegfilgrastim SD-01-filgrastim XM22 N-(3-hydroxypropyl)methionylcolony-stimulating factor (human), 1-ether with alpha-methyl-omega-hydroxypoly(oxyethylene) PEG-rmetHuG-CSF XM-22 Neulasta SD-01, polyethylene glycol-conjugated filgrastim LA-EP2006
|
|
| cui |
C5441855 C1171279 C3640212 C4083253 C3641684 C1136535
|
|
| HM |
D011092 D000069585
|
|
| Inverse of RB |
4AWF0N6QV3 3A58010674 0
|
|
| LT |
TRD
|
|
| Mapped to | ||
| MDA |
20020606
|
|
| MeSH Frequency |
702
|
|
| MMR |
20180924
|
|
| notation |
C455861
|
|
| prefLabel |
pegfilgrastim
|
|
| RR |
4AWF0N6QV3
|
|
| SC |
1
|
|
| Scope Statement |
pegylated (r-G-CSF) conjugated to polyethylene glycol for treatment of neutropenic patients with non-myeloid malignancies who are at high risk for infection
|
|
| SRC |
Med Lett Drugs Ther 2002 May 13;44(1130):44-5
|
|
| TERMUI |
T000916839 T419953 T000901411 T496970 T419952 T835028 T835029 T000946982 T595111 T419954 T496969
|
|
| TH |
US NLM (2016) NLM (2002) NLM (2004) NLM (2000) FDA SRS (2017) USAN (2004) USAN (19XX) INN (19XX) DE NLM (2017) FDA SRS (2012) NLM (2014)
|
|
| tui |
T116 T129 T121
|
Add comment
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |
Create mapping